BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12536240)

  • 1. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.
    Jacobs R; Hintzen G; Kemper A; Beul K; Kempf S; Behrens G; Sykora KW; Schmidt RE
    Eur J Immunol; 2001 Oct; 31(10):3121-7. PubMed ID: 11592089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia.
    Morice WG; Kurtin PJ; Leibson PJ; Tefferi A; Hanson CA
    Br J Haematol; 2003 Mar; 120(6):1026-36. PubMed ID: 12648073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties.
    Lima M; Teixeira MA; Queirós ML; Leite M; Santos AH; Justiça B; Orfão A
    Blood Cells Mol Dis; 2001; 27(4):731-43. PubMed ID: 11778657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
    J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal age related change in natural killer cell receptors for MHC class I.
    Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
    Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
    Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
    J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease.
    Takeno M; Shimoyama Y; Kashiwakura J; Nagafuchi H; Sakane T; Suzuki N
    Rheumatol Int; 2004 Jul; 24(4):212-6. PubMed ID: 12879269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules.
    Lundell R; Hartung L; Hill S; Perkins SL; Bahler DW
    Am J Clin Pathol; 2005 Dec; 124(6):937-46. PubMed ID: 16416744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of killer immunoglobulin-like receptors on peripheral blood NK cell subsets of women with recurrent spontaneous abortions or implantation failures.
    Ntrivalas EI; Bowser CR; Kwak-Kim J; Beaman KD; Gilman-Sachs A
    Am J Reprod Immunol; 2005 May; 53(5):215-21. PubMed ID: 15833099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.
    Vĕtvicka V; Hanikýrová M; Vĕtvicková J; Ross GD
    Clin Exp Immunol; 1999 Feb; 115(2):229-35. PubMed ID: 9933447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.
    Eidukaite A; Siaurys A; Tamosiunas V
    Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells and their receptors.
    Middleton D; Curran M; Maxwell L
    Transpl Immunol; 2002 Aug; 10(2-3):147-64. PubMed ID: 12216946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.